Tech Company Financing Transactions
X-Therma Funding Round
On 3/13/2024, X-Therma raised $22.4 million in Series B funding from LOREA AG, Starling Locke Capital and private investors.
Transaction Overview
Company Name
Announced On
3/13/2024
Transaction Type
Venture Equity
Amount
$22,400,000
Round
Series B
Investors
LOREA AG (Lead Investor)
Starling Locke Capital (Lead Investor)
Proceeds Purpose
The investment enables X-Therma to scale global commercial operations and facilitates the company's progression into the clinical stage with Food and Drug Administration (FDA) Breakthrough Device status, aimed at significantly increasing organ availability for transplantation by overcoming time-sensitive limitations.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2600 Hilltop Dr. B220
Richmond, CA 94806
USA
Richmond, CA 94806
USA
Phone
Undisclosed
Website
Email Address
Overview
Inspired by nature, empowered by advanced nanoscience. X-Therma stops ice to unlock the full benefits of low-temperature for human health and comfort. We dedicate ourselves to support and accelerate continued advancements in regenerative medicine by extending time exactly where every minute matters.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xiaoxi Wei
Chief Technical Officer
Mark Kline
Browse more venture capital transactions:
Prev: 3/13/2024: Metica venture capital transaction
Next: 3/14/2024: Quintessent venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs